Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to Shareholders from CEO and President Michael Feldschuh.

Read more at globenewswire.com